Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: right (637), accurate (173), exact (69), truthful (3), proper (58), acceptable (96), put right (222)

Carboplatin AUC1.5+RT

Description: Chemotherapy Protocol HEAD AND NECK CANCER CARBOPLATIN (AUC1.5)-RADIOTHERAPY Regimen • Head and Neck Cancer – Carboplatin(AUC1.5)-Radiotherapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Carboplatin-AUC1.5RT.pdf

HSCTCyclophosphamide-Priming-1500

Description: Chemotherapy Protocol Haematopoietic Stem Cell Transplant (Autograft) CYCLOPHOSPHAMIDE PRIMING (1500mg/m2) Regimen • Haematopoietic Stem Cell
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/hsctcyclophosphamide-priming-1500.pdf

Ponatinib

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Ponatinib All licensed indications are not funded therefore an application for funding is req
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Ponatinib.pdf

ImatinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (chronic phase) • CML – Imatinib (chronic phase) Indication • As the preferr
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibChronic.pdf

ImatinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (accelerated phase) • CML - Imatinib (accelerated phase) Indication • As the
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibAccelerated.pdf

DasatinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (chronic phase) Funding may be required for specific indications Regimen • CML – Da
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibChronic.pdf

DasatinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (accelerated phase) Funding may be required for specific indications Regimen • CML
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibAccelerated.pdf

Capecitabine 1250 (14)

Description: Chemotherapy Protocol BREAST CANCER CAPECITABINE 1250 (14 day) Regimen • Breast Cancer – Capecitabine 1250 (14 day) Indication • Treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine1250-14.pdf

Capecitabine 1000 (14)

Description: Chemotherapy Protocol BREAST CANCER CAPECITABINE 1000 (14 day) Regimen • Breast Cancer – Capecitabine 1000 (14 day) Indication • Treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine1000-14.pdf

SHC_application_2021_final2

Description: Southampton Hospitals Charity Research Funding Award 2022 Southampton Hospitals Charity (SHC) has actively engaged in raising funds for
Url: /Media/Southampton-Clinical-Research/Grants/Download/SHC-application-2021-final2.docx

401 to 410 of 815

Previous … 39 40 41 42 43 … Next